Regional regulatory processes for the approval of biosimilars; differences and similarities

Abstract: The situation in many countries regarding the procedure used to evaluate ‘biosimilars’ is not always clear. In this issue of GaBI Journal, Azevedo et al. review the regulatory situation… Read More »